NCT00769587 2025-09-22
Thalidomide in Treating Patients With Relapsed or Progressive Systemic Mastocytosis
Centre Hospitalier Universitaire, Amiens
Completed
Clinical Trials
19 trialsNCT07142473 2025-08-26
MaRe
Fondazione IRCCS Policlinico San Matteo di Pavia
Recruiting
NCT00449748 2025-05-01
Everolimus (RAD001) as Therapy for Patients With Systemic Mastocytosis
M.D. Anderson Cancer Center
Phase 2 Completed
NCT06065007 2025-04-04
Quality of Life and Disease-related Symptoms in Individuals With Systemic Mastocytosis
Uppsala University
Active not recruiting
NCT03401060 2024-05-03
DenosuMast
Assistance Publique - Hôpitaux de Paris
Phase 3 Completed
NCT06210698 2024-01-18
Angioedema Biomarker Research Study
Foundation For Rare Disease Research
Unknown
NCT06013683 2023-10-10
A Registry for Patients With Systemic Mastocytosis in China
The First Affiliated Hospital of Soochow University
Unknown
NCT05923372 2023-07-12
DALY-MAST
University Hospital, Toulouse
Unknown
NCT01334996 2020-04-10
Use of Tamoxifen in Systemic Mastocytosis
Mayo Clinic
Completed
NCT03632811 2019-07-17
Mc_QoL
University Hospital, Toulouse
Completed
NCT02441166 2019-07-15
EvaTryMS
University Hospital, Toulouse
Phase NA Completed
NCT01807598 2019-01-29
Brentuximab Vedotin in Treating Patients With Advanced Systemic Mastocytosis or Mast Cell Leukemia
Stanford University
Phase 2 Completed
NCT02415608 2018-09-20
Ibrutinib in Treating Patients With Advanced Systemic Mastocytosis
Stanford University
Phase 2 Terminated
NCT01297777 2016-08-29
Imatinib in KIT-negative Systemic Mastocytosis
Hospital Virgen de la Salud
Phase 4 Completed
NCT01602939 2016-08-29
Cladribine Plus Pegylated Interpheron Alfa-2a in Systemic Mastocytosis
Hospital Virgen de la Salud
Phase 2/3 Unknown
NCT01920204 2015-01-19
Midostaurin in Indolent Systemic Mastocytosis
University Medical Center Groningen
Phase 2 Unknown
NCT00493129 2012-02-08
Ontak (Denileukin Diftitox) in Patients With Systemic Mastocytosis (SM)
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00918931 2011-11-04
Obatoclax for Systemic Mastocytosis
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT00979160 2009-09-18
Evaluation of Response of Dasatinib to Treat Mastocytosis
Federico II University
Phase 2 Unknown